The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Brolucizumab (Vsiqq) is indicated for the treatment of: Neovascular (wet) age-related macular degeneration (AMD).
Visual impairment due to diabetic macular edema (DME).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education